scholarly journals Gene-specific selection against experimental fanconi anemia gene inactivation in human cancer

2007 ◽  
Vol 6 (5) ◽  
pp. 654-660 ◽  
Author(s):  
Eike Gallmeier ◽  
Tomas Hucl ◽  
Eric S. Calhoun ◽  
Steven C. Cunningham ◽  
Fred Bunz ◽  
...  
2015 ◽  
Vol 5 (7) ◽  
pp. e323-e323 ◽  
Author(s):  
M T Voso ◽  
E Fabiani ◽  
Z Zang ◽  
L Fianchi ◽  
G Falconi ◽  
...  

Blood ◽  
1995 ◽  
Vol 86 (11) ◽  
pp. 4034-4038 ◽  
Author(s):  
PC Verlander ◽  
A Kaporis ◽  
Q Liu ◽  
Q Zhang ◽  
U Seligsohn ◽  
...  

Fanconi anemia (FA) is a genetically and phenotypically heterogeneous autosomal recessive disorder defined by a cellular hypersensitivity to DNA cross-linking agents. One of the FA genes, FAC, has been cloned and the genomic structure of the coding region has been characterized. We have developed amplification refractory mutation system (ARMS) assays for five known mutations in FAC, and have applied these assays to determine the carrier frequency of the IVS4 + 4 A-->T (IVS4) mutation in an Ashkenazi Jewish population. We tested 3,104 Jewish individuals, primarily of Ashkenazi descent, for the two most common FAC mutations, IVS4 and 322delG. Thirty-five IVS4 carriers were identified, for a carrier frequency of 1 in 89 (1.1%; 95% confidence interval 0.79% to 1.56%); no 322delG carriers were found. To determine if the IVS4 mutation was confined to the Ashkenazi Jewish population, we tested 563 Iraqi Jews for IVS4, and no carriers were found. Because the IVS4 mutation has only been found on chromosomes of Ashkenazi Jewish origin and is the only FAC mutation found on these chromosomes, we suggest that a founder effect is responsible for the high frequency of this mutation. With a carrier frequency greater than 1% and simple testing available, the IVS4 mutation merits inclusion in the battery of tests routinely provided to the Jewish population.


2001 ◽  
Vol 7 (2) ◽  
pp. 241-248 ◽  
Author(s):  
Cynthia Timmers ◽  
Toshiyasu Taniguchi ◽  
James Hejna ◽  
Carol Reifsteck ◽  
Lora Lucas ◽  
...  

2018 ◽  
Author(s):  
Emily Yun-chia Chang ◽  
James P. Wells ◽  
Shu-Huei Tsai ◽  
Yan Coulombe ◽  
Yujia A. Chan ◽  
...  

SUMMARYEctopic R-loop accumulation causes DNA replication stress and genome instability. To avoid these outcomes, cells possess a range of anti-R-loop mechanisms, including RNaseH that degrades the RNA moiety in R-loops. To comprehensively identify anti-R-loop mechanisms, we performed a genome-wide trigenic interaction screen in yeast lacking RNH1 and RNH201. We identified >100 genes critical for fitness in the absence of RNaseH, which were enriched for DNA replication fork maintenance factors such as RAD50. We show in yeast and human cells that R-loops accumulate during RAD50 depletion. In human cancer cell models, we find that RAD50 and its partners in the MRE11-RAD50-NBS1 complex regulate R-loop-associated DNA damage and replication stress. We show that a non-nucleolytic function of MRE11 is important for R-loop suppression via activation of PCNA-ubiquitination by RAD18 and recruiting anti-R-loop helicases in the Fanconi Anemia pathway. This work establishes a novel role for MRE11-RAD50-NBS1 in directing tolerance mechanisms of transcription-replication conflicts.


Blood ◽  
1991 ◽  
Vol 77 (4) ◽  
pp. 833-840 ◽  
Author(s):  
AM Ginsberg ◽  
M Raffeld ◽  
J Cossman

Abstract The absence of wild type retinoblastoma (Rb) gene expression in a wide variety of human solid tumors suggests an etiologic role for this tumor suppressor gene in human cancer. We have evaluated the involvement of Rb gene inactivation in the pathogenesis and progression of human lymphoma and leukemia. We examined the genomic configuration and transcription of the Rb gene in cultured cell lines and primary cases of T- and B-cell lymphomas and leukemias. By Southern analysis, abnormalities of the Rb locus were identified in 1 of 5 T-cell acute lymphoblastic lymphoma (T-ALL) cell lines, 1 of 26 primary cases of T- ALL, 1 of 40 primary cases of chronic lymphocytic lymphoma/well- differentiated lymphoma (CLL/WDL), and 1 of 15 primary cases of intermediately differentiated lymphoma (IDL). By Northern analysis, markedly reduced or abnormal expression of the Rb gene was identified in 2 of 5 T-ALL cell lines, 1 of 7 primary cases of T-ALL, 1 of 5 primary cases of CLL/WDL, and 1 of 6 primary cases of IDL. These findings show that Rb gene inactivation can be associated with a broad range of lymphoid neoplasms and that loss of the tumor suppressor function of Rb may influence the pathogenesis and progression of lymphoma/leukemia.


2015 ◽  
Vol 26 (2) ◽  
pp. 114-126 ◽  
Author(s):  
Mark J. Osborn ◽  
Richard Gabriel ◽  
Beau R. Webber ◽  
Anthony P. DeFeo ◽  
Amber N. McElroy ◽  
...  

2009 ◽  
Vol 11 (11) ◽  
pp. 1012-1019 ◽  
Author(s):  
Kittiphong Paiboonsukwong ◽  
Fumi Ohbayashi ◽  
Haruka Shiiba ◽  
Emi Aizawa ◽  
Takayuki Yamashita ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document